Net debt decreased 27.8%
Net debt changed -27.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net debt changed -27.8% from the comparable as-filed period.
Free-cash-flow proxy changed +1503.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Free-cash-flow margin changed +2209 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +2132 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -260 basis points from the comparable as-filed period.
Capital expenditure changed -44.6% from the comparable as-filed period.
Cash / debt changed +1618 basis points from the comparable as-filed period.
Current ratio changed +173.0% from the comparable as-filed period.
Debt / revenue changed -818 basis points from the comparable as-filed period.
Working capital / assets changed +2262 basis points from the comparable as-filed period.
Trade receivables changed -11.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -840 basis points from the comparable as-filed period.
Inventory / revenue changed -193 basis points from the comparable as-filed period.
Revenue changed +1.0% from the comparable as-filed period.
Working capital changed +188.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Capex / revenue changed -77 basis points from the comparable as-filed period.
Total assets changed -3.8% from the comparable as-filed period.
Research & development changed -5.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +5.6% from the comparable as-filed period.
Current assets changed +4.7% from the comparable as-filed period.
Inventory changed -3.1% from the comparable as-filed period.
Debt / assets changed -37 basis points from the comparable as-filed period.
R&D / revenue changed -51 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.